ArticleJournal for immunotherapy of cancer2021

Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial.

Johnny Duerinck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.